Targeting NTRK in NSCLC

Episode
98
Soundcloud
Share

In this episode of Lung Cancer Considered, host Dr. Narjust Duma talks with Dr. Robert C. Doebele, Co-Founder and Chief Scientific Officer, Rain Therapeutics about NTKR gene fusions, including recent and emerging breakthrough therapies.

Guest
Narjust Florez
Narjust Florez

MD

Associate Director of the Cancer Care Equity Program and Assistant Professor of Medicine
Dana-Farber Cancer Institute
Harvard Medical School

Other Podcast

WCLC 2023 Recap on Lung Cancer Considered
Episode
177
Live from WCLC Monday Highlights
Episode
174